EPITOPE SUMMARY | |
---|---|
VLNDILSRL is a linear peptidic epitope (epitope ID ) studied as part of Spike glycoprotein (UniProt:P0DTC2) from SARS-CoV2 and Spike glycoprotein (UniProt:P59594) from SARS-CoV1. This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, MHC ligand assays and has 3D structure(s) . |
CURATED EXPERIMENTAL DATA | |
---|---|
MHC Ligand Assay(s) | |
MHC molecule | Positive / All |
HLA-A*02:01 | / |
HLA-A2 | / |
HLA-C*07:01 | / |
HLA-E*01:01 | / |
HLA-E*01:03 | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
qualitative binding | / |
IFNg release | / |
activation | / |
TNFa release | / |
IL-2 release | / |
cytotoxicity | / |
degranulation | / |
EXTERNAL RESOURCES | |
---|---|
Resource | Link |